# Nicotine Polacrilex

NDC: 45802-344
Generic name: Nicotine Polacrilex
Labeler / Manufacturer: Padagis Israel Pharmaceuticals Ltd
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: LOZENGE
Routes: ORAL
Marketing started: 20140331

FDA application: ANDA077007

## Active ingredients

- NICOTINE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"45802-344"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=45802-344
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=157e5479-28d6-4493-a8cf-597b9e5622c0